| |
| Magyar Dermatológiai Társulat |
|
| 1st European School of Dermato-Oncology (EADO) |
 Rendezvény kezdete: 2013.01.17. | Rendezvény vége: 2013.01.19. |
| Szakterület(ek): Bőrgyógyászat |
| Helyszín: Germany, 10117 Berlin, NH Berlin Friedrichstrasse, NH Berlin Friedrichstrasse |
| A rendezvény Web oldala: http://www.dermato-oncology2013.com/ |
The EADO initiates a course dedicated to fundamentals in skin cancer targeted to specialists and residents in the final phase of their resident program. They will benefit a comprehensive and updated course to improve their decision-making process for the management of all types and stages of skin cancer, from diagnosis, primary treatment and adjuvant treatment, to the management of loco-regional disease and distant metastatic disease. It is intended to organize this course every year in different countries.
Target Audience
This 2,5-day educational course targets doctors who are actively involved in the treatment of skin cancer. Dermatologists or other specialists who have completed specialist training, or residents in the final year of their training program, are likely to gain the most from this course.
The maximum number of delegates is 100. In order to make the course available throughout Europe, places will be made available on a first come first served basis to all applicants.
|
|
|
 |
| |
| Magyar Dermatológiai Társulat |
|
| 1st European School of Dermato-Oncology (EADO) |
| Rendezvény kezdete: 2013.01.17. | Rendezvény vége: 2013.01.19. |
| Szakterület(ek): Bőrgyógyászat |
| Helyszín: Germany, 10117 Berlin, NH Berlin Friedrichstrasse, NH Berlin Friedrichstrasse |
| A rendezvény Web oldala: http://www.dermato-oncology2013.com/ |
The EADO initiates a course dedicated to fundamentals in skin cancer targeted to specialists and residents in the final phase of their resident program. They will benefit a comprehensive and updated course to improve their decision-making process for the management of all types and stages of skin cancer, from diagnosis, primary treatment and adjuvant treatment, to the management of loco-regional disease and distant metastatic disease. It is intended to organize this course every year in different countries.
Target Audience
This 2,5-day educational course targets doctors who are actively involved in the treatment of skin cancer. Dermatologists or other specialists who have completed specialist training, or residents in the final year of their training program, are likely to gain the most from this course.
The maximum number of delegates is 100. In order to make the course available throughout Europe, places will be made available on a first come first served basis to all applicants.
|
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| C-HEP 2012 - 2nd World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
| Rendezvény kezdete: 2012.10.18. | Rendezvény vége: 2012.10.20. |
| Helyszín: Germany / Németország, Berlin, |
| A rendezvény Web oldala: http://comtecmed.com/chep/2012/Default.aspx |
Dear Friends and Colleagues,
Following the success of the 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep), we are very pleased to invite you to participate in the 2nd C-Hep Congress which will be held in Berlin, Germany on October 18-20, 2012.
The large attendance and enthusiastic feedback of the 1st Congress held last May in Barcelona highlighted the need for such a meeting focusing on the needs of the busy clinician caring for HCV and HBV infected patients. The C-Hep Congress attempts to summarize all the key new data recently presented – and how it might be implemented in routine care of Hepatitis B and C patients. Overviews, state of the art lectures and controversial debates with the outstanding faculty of prominent world leaders presenting both pro and con positions challenge and explore the optimal treatment for patients, including the appropriate use of new drugs. This educational Congress focuses on clinical practices in Viral Hepatitis and benefits not only Hepatologists and Infectious Diseases specialist, but also general practitioners, internists and primary care physicians with a desire to gain knowledge in these exciting advances.
The format includes a significant allocation of time for interactive debates and questions from the audience to each panel of experts. Participants are encouraged to take an active role in the discussions with faculty members which follow each debate, in a unique and open environment.
We look forward to welcoming you at the 2nd C-Hep Congress in the lovely city of Berlin.
Sincerely,
Jürgen Rockstroh MD (Germany) and Jonathan M. Schapiro MD (Israel)
(Co-Chairpersons) |
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| C-HEP 2012 - 2nd World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
| Rendezvény kezdete: 2012.10.18. | Rendezvény vége: 2012.10.20. |
| Helyszín: Germany / Németország, Berlin, |
| A rendezvény Web oldala: http://comtecmed.com/chep/2012/Default.aspx |
Dear Friends and Colleagues,
Following the success of the 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep), we are very pleased to invite you to participate in the 2nd C-Hep Congress which will be held in Berlin, Germany on October 18-20, 2012.
The large attendance and enthusiastic feedback of the 1st Congress held last May in Barcelona highlighted the need for such a meeting focusing on the needs of the busy clinician caring for HCV and HBV infected patients. The C-Hep Congress attempts to summarize all the key new data recently presented – and how it might be implemented in routine care of Hepatitis B and C patients. Overviews, state of the art lectures and controversial debates with the outstanding faculty of prominent world leaders presenting both pro and con positions challenge and explore the optimal treatment for patients, including the appropriate use of new drugs. This educational Congress focuses on clinical practices in Viral Hepatitis and benefits not only Hepatologists and Infectious Diseases specialist, but also general practitioners, internists and primary care physicians with a desire to gain knowledge in these exciting advances.
The format includes a significant allocation of time for interactive debates and questions from the audience to each panel of experts. Participants are encouraged to take an active role in the discussions with faculty members which follow each debate, in a unique and open environment.
We look forward to welcoming you at the 2nd C-Hep Congress in the lovely city of Berlin.
Sincerely,
Jürgen Rockstroh MD (Germany) and Jonathan M. Schapiro MD (Israel)
(Co-Chairpersons) |
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| C-HEP 2012 - 2nd World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
| Rendezvény kezdete: 2012.10.18. | Rendezvény vége: 2012.10.20. |
| Helyszín: Germany / Németország, Berlin, |
| A rendezvény Web oldala: http://comtecmed.com/chep/2012/Default.aspx |
Dear Friends and Colleagues,
Following the success of the 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep), we are very pleased to invite you to participate in the 2nd C-Hep Congress which will be held in Berlin, Germany on October 18-20, 2012.
The large attendance and enthusiastic feedback of the 1st Congress held last May in Barcelona highlighted the need for such a meeting focusing on the needs of the busy clinician caring for HCV and HBV infected patients. The C-Hep Congress attempts to summarize all the key new data recently presented – and how it might be implemented in routine care of Hepatitis B and C patients. Overviews, state of the art lectures and controversial debates with the outstanding faculty of prominent world leaders presenting both pro and con positions challenge and explore the optimal treatment for patients, including the appropriate use of new drugs. This educational Congress focuses on clinical practices in Viral Hepatitis and benefits not only Hepatologists and Infectious Diseases specialist, but also general practitioners, internists and primary care physicians with a desire to gain knowledge in these exciting advances.
The format includes a significant allocation of time for interactive debates and questions from the audience to each panel of experts. Participants are encouraged to take an active role in the discussions with faculty members which follow each debate, in a unique and open environment.
We look forward to welcoming you at the 2nd C-Hep Congress in the lovely city of Berlin.
Sincerely,
Jürgen Rockstroh MD (Germany) and Jonathan M. Schapiro MD (Israel)
(Co-Chairpersons) |
|
|
|
